Page 3 - Voir-Entendre_BAT_fr

An innovative and Major breakthroughs

high-performing ecosystem Proof of concept that sonogenetics can induce
visual perception in a blind patient through a
18 research teams, one exclusively dedicated combination of gene therapy and ultrasound
to partnership research
Partial restoration of vision in a blind patient using
Labeled as IHU (Institut Hospitalo-Universitaire) optogenetic therapy
in 2019
Modeling of pathologies with organoids to
Founding member of the Biocluster validate different ex vivo therapeutic approaches
«Brain & Mind»
3D imaging in retinal organoids enabling long-
12 spin-offs: term non-invasive imaging
• €700M raised
• 2 companies listed on the stock exchange Study of a promising gene therapy to treat
• 1 acquisition by Sanofi (Fovea) auditory impairments and complete congenital
stationary night blindness
World-first achievements:
• Optogenetics
• Sonogenetics
Partnerships at the heart

of our strategy
KEY FIGURES

336

Permanent staff
(full-time equivalent)

86

PhD students

6,4 M€

Partnership incomes
with industry